首页> 外国专利> heterocyclic compounds, in particular, indole compounds, processes for preparation thereof and pharmaceutical preparations containing these compounds as active component.

heterocyclic compounds, in particular, indole compounds, processes for preparation thereof and pharmaceutical preparations containing these compounds as active component.

机译:杂环化合物,特别是吲哚化合物,其制备方法和含有这些化合物作为活性成分的药物制剂。

摘要

Compounds are disclosed of general formula (I): IMAGE (I) wherein R1 and R2 each independently represents a hydrogen atom, or an aryl, aralkyl, cycloalkyl, fluoroalkyl or alkyl group, which alkyl group is optionally substituted by an alkenyl group or by a group -OR7 or by IMAGE where R7 and R8 each independently represents a hydrogen atom, an alkyl, aryl or aralkyl group; or R1 and R2 together with the nitrogen atom to which they are attached form a saturated monocyclic 5 to 7 membered ring which may contain a further hetero function (viz-O-, -NH or IMAGE R3 and R4 have the same meanings as R1 and R2 and may together form an aralkylidene group; R5 represents a hydrogen atom or an alkyl or aralkyl group; R6 represents a hydrogen atom or an aryl or C1-C3 alkyl group; Alk represents an C1-C4 alkylene group optionally substituted at one or more of its carbon atoms by one to three C1-C3 alkyl groups; and X represents an oxygen or sulphur atom, and its physiologically acceptable salts, hydrates and bioprecursors. The indoles (I) may be prepared by combinations of reactions to introduce the desired substituents into suitable intermediates either before or after cyclization to form the indole nucleus. The compounds have selective actions on blood vessels and, in particular exhibit antihypertensive properties. They may be formulated in conventional manner as pharmaceutical compositions.
机译:公开了具有通式(I)的化合物:<图像>(I),其中R 1和R 2各自独立地代表氢原子,或芳基,芳烷基,环烷基,氟代烷基或烷基,其中烷基任选地被烯基取代或者通过-OR7基团或通过,其中R7和R8各自独立地表示氢原子,烷基,芳基或芳烷基;或R 1和R 2与它们所连接的氮原子一起形成饱和的5至7元单环,该环可以进一步包含杂功能(viz-O-,-NH或,R 3和R 4的含义与R 1和R 2可以一起形成亚芳烷基; R 5代表氢原子或烷基或芳烷基; R 6代表氢原子或芳基或C 1 -C 3烷基; Alk代表任选地被一个或多个取代的C 1 -C 4亚烷基。 (I)的吲哚可以通过结合反应的方法来制备,其中的一个或多个碳原子带有一个或三个C1-C3烷基; X表示氧或硫原子,以及其生理上可接受的盐,水合物和生物前体。在环化形成吲哚核之前或之后,将所需的取代基转变成合适的中间体,该化合物对血管具有选择性作用,特别是具有降压作用,可以按常规方法配制作为药物组合物。

著录项

  • 公开/公告号NL7907583A

    专利类型

  • 公开/公告日1980-04-15

    原文格式PDF

  • 申请/专利权人 GLAXO GROUP LIMITED TE LONDEN.;

    申请/专利号NL19790007583

  • 发明设计人

    申请日1979-10-12

  • 分类号C07D209/14;A61K31/40;

  • 国家 NL

  • 入库时间 2022-08-22 18:28:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号